SIMPLEX TRADING, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 4 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$3,776
-55.6%
83,200
-45.1%
0.00%
-57.1%
Q2 2023$8,510
+111.0%
151,600
+70.0%
0.01%
+75.0%
Q1 2023$4,034
-44.3%
89,200
-49.9%
0.00%
-50.0%
Q4 2022$7,239
-99.9%
178,100
+61.5%
0.01%0.0%
Q3 2022$7,208,000
-6.3%
110,300
-12.9%
0.01%0.0%
Q2 2022$7,693,000
+69.1%
126,600
+74.6%
0.01%
+100.0%
Q1 2022$4,550,000
-64.7%
72,500
-57.4%
0.00%
-69.2%
Q4 2021$12,897,000
-5.1%
170,200
+96.1%
0.01%0.0%
Q3 2021$13,596,000
-0.8%
86,800
+2.5%
0.01%0.0%
Q2 2021$13,712,000
+31.5%
84,700
+9794.9%
0.01%
-31.6%
Q1 2021$10,430,000
-27.1%
856
-8.4%
0.02%0.0%
Q4 2020$14,315,000
+397.6%
935
+171.8%
0.02%
+375.0%
Q3 2020$2,877,000
-22.2%
344
-31.6%
0.00%
-33.3%
Q2 2020$3,696,000
+174.2%
503
+58.2%
0.01%
+200.0%
Q1 2020$1,348,000
-28.1%
318
+3.2%
0.00%
-50.0%
Q4 2019$1,875,000
+59.4%
308
+7.3%
0.00%
+33.3%
Q3 2019$1,176,000
-47.2%
287
-39.3%
0.00%
-50.0%
Q2 2019$2,227,000
+46.7%
473
+11.3%
0.01%
+50.0%
Q1 2019$1,518,000
+79.6%
425
+43.6%
0.00%
+100.0%
Q4 2018$845,000
+144.9%
296
+279.5%
0.00%
+100.0%
Q3 2018$345,000
+73.4%
78
+129.4%
0.00%0.0%
Q2 2018$199,000
+352.3%
34
+54.5%
0.00%
-50.0%
Q1 2018$44,000
+300.0%
22
+100.0%
0.00%
Q4 2017$11,00011
+266.7%
0.00%
Q3 2017$0
-100.0%
3
-85.0%
0.00%
Q2 2017$1,000200.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 444,300$68,027,0000.12%
Marathon Trading Investment Management LLC 3,400$521,0000.03%
SIMPLEX TRADING, LLC 935$14,315,0000.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders